328 related articles for article (PubMed ID: 36572064)
1. Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management.
Baumrin E; Loren AW; Falk SJ; Mays JW; Cowen EW
J Am Acad Dermatol; 2024 Jan; 90(1):19-36. PubMed ID: 36572064
[TBL] [Abstract][Full Text] [Related]
2. Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.
Baumrin E; Loren AW; Falk SJ; Mays JW; Cowen EW
J Am Acad Dermatol; 2024 Jan; 90(1):1-16. PubMed ID: 36572065
[TBL] [Abstract][Full Text] [Related]
3. Chronic graft-versus-host disease in pediatric patients: Differences and challenges.
Haroun E; Agrawal K; Leibovitch J; Kassab J; Zoghbi M; Dutta D; Lim SH
Blood Rev; 2023 Jul; 60():101054. PubMed ID: 36805299
[TBL] [Abstract][Full Text] [Related]
4. Recent advances and research progress in biomarkers for chronic graft versus host disease.
Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in prevention and treatment of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Toubai T; Hosokawa Y
Rinsho Ketsueki; 2024; 65(5):401-411. PubMed ID: 38825520
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis and Therapeutic Prospects of Chronic Graft-Versus-Host Disease --Review].
Xu SH; Man Y; Zhao JL; Wang YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):647-652. PubMed ID: 38660881
[TBL] [Abstract][Full Text] [Related]
7. [Chronic graft-versus-host disease].
Rørvik SD; Abrahamsen IW; Myhre AE; Vo CD; Ødegaard EM; Bruserud Ø; Gedde-Dahl T; Tvedt THA
Tidsskr Nor Laegeforen; 2023 Mar; 143(4):. PubMed ID: 36919292
[TBL] [Abstract][Full Text] [Related]
8. Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation.
Shimomura Y; Kitamura T; Murata M; Matsuo K; Ito Y; Ichinohe T; Hashii Y; Goto H; Kato K; Ishimaru F; Sato A; Onizuka M; Yanagisawa A; Ohbiki M; Tabuchi K; Atsuta Y; Fukuda T; Kanda J; Terakura S
Transplant Cell Ther; 2024 Mar; 30(3):326.e1-326.e14. PubMed ID: 38218451
[TBL] [Abstract][Full Text] [Related]
9. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-
Bos S; Murray J; Marchetti M; Cheng GS; Bergeron A; Wolff D; Sander C; Sharma A; Badawy SM; Peric Z; Piekarska A; Pidala J; Raj K; Penack O; Kulkarni S; Beestrum M; Linke A; Rutter M; Coleman C; Tonia T; Schoemans H; Stolz D; Vos R
Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38485149
[TBL] [Abstract][Full Text] [Related]
10. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
[TBL] [Abstract][Full Text] [Related]
11. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
[TBL] [Abstract][Full Text] [Related]
12. Updates in chronic graft-versus-host disease management.
Malard F; Mohty M
Am J Hematol; 2023 Oct; 98(10):1637-1644. PubMed ID: 37483142
[TBL] [Abstract][Full Text] [Related]
13. Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists.
Martínez-Maestre MÁ; Castelo-Branco C; Calderón AM; Espigado I; Pérez-Simón JA; González-Cejudo C
Climacteric; 2024 Jun; 27(3):275-281. PubMed ID: 38415712
[TBL] [Abstract][Full Text] [Related]
14. Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case.
Ganta CC; Chatterjee S; Pohlman B; Hojjati M
J Clin Rheumatol; 2015 Mar; 21(2):86-94. PubMed ID: 25710860
[TBL] [Abstract][Full Text] [Related]
15. Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management.
Hull K; Kerridge I; Avery S; McCullough M; Ritchie D; Szer J
Intern Med J; 2015 Jul; 45(7):702-10. PubMed ID: 26134695
[TBL] [Abstract][Full Text] [Related]
16. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Kim DDH; Popradi G; Lepic K; Paulson K; Allan D; Nampoothiri RV; Lachance S; Deotare U; White J; Elemary M; Jamani K; Fraga C; Lemieux C; Novitzky-Basso I; Law AD; Kumar R; Walker I; Schultz KR;
Curr Oncol; 2024 Mar; 31(3):1426-1444. PubMed ID: 38534941
[TBL] [Abstract][Full Text] [Related]
17. Vulvovaginal Graft-Versus-Host Disease.
Kornik RI; Rustagi AS
Obstet Gynecol Clin North Am; 2017 Sep; 44(3):475-492. PubMed ID: 28778644
[TBL] [Abstract][Full Text] [Related]
18. Survey of European Blood and Marrow Transplant (EBMT) nurses to explore the current topical skin management of chronic cutaneous graft versus host disease in the real-world clinical environment.
Murray J; Liptrott S; Canesi M; Mooyaart J; Kisch A; Piepenbroek B; Stringer J
Eur J Oncol Nurs; 2024 Apr; 69():102547. PubMed ID: 38467081
[TBL] [Abstract][Full Text] [Related]
19. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.
Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H
Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105
[TBL] [Abstract][Full Text] [Related]
20. Steroid-Refractory Chronic Graft-Versus-Host Disease: Treatment Options and Nursing Care.
Cazeau N; Rodriguez S
Clin J Oncol Nurs; 2023 May; 27(3):259-265. PubMed ID: 37267484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
